Good news, saving money again!

On July 12, the results of the seventh batch of nationally-organized centralized drug procurement to be carried out by a purchasing alliance formed by various provinces across the country were released!

In this collection, 60 kinds of drugs were successfully purchased, including common diseases such as hypertension, diabetes, anti-infection, and digestive tract diseases. , drugs for chronic diseases, and drugs for major diseases such as lung cancer, liver cancer, kidney cancer, and bowel cancer.

The average price of selected drugs is reduced by 48%! According to the agreed procurement volume, it is estimated that the annual cost savings will be 18.5 billion yuan.

As soon as the message comes out,

Netizens were moved to tears!

"Wow, good country"

"Thank you country"

…

What is centralized medicine procurement? Brief talk

collective collection of medicinesIt is by summarizing the actual clinical needs of medical institutions in exchange for pharmaceutical companies to provide drugs at lower prices. Therefore, the varieties collected each time, as well as the purchase amount of each variety, will also be adjusted according to clinical needs.

From the drug price monitoring data carried out by the Medical Insurance Bureau, since the implementation of centralized procurement, the overall price level of drugs has continued to decline, and the top six The average drop of 53% in the centralized procurement of medicines organized by the state has effectively squeezed the space for inflated drug prices.

This collection of medicines31 treatment categories involved

includeshypertension, diabetes, anti-infection, digestive tractDiseases, etc.Common diseases, chronic diseasesmedication, andLung cancer, liver cancer, kidney cancer, bowel cancerand other major diseases , the masses have a wide range of benefits and a strong sense of gain.

Taking the first-line targeted drug lenvatinib capsules for liver cancer as an example, each capsule dropped from an average of 108 yuan to an average of 18 yuan, A treatment cycle can save 8100 yuan.

In the field of blood pressure lowering, it was the first time to include sustained and controlled release dosage forms. Nifedipine controlled release tablets were reduced in price by 58%, metoprolol delayed The price of release tablets was reduced by 53%, and the drug burden of hypertensive patients was significantly reduced.

The antiviral drug oseltamivir dropped from an average of 4.5 yuan to 1 yuan per tablet.

In addition, Pfizer's tigecycline, Japan's Astellas' Micafungin, Spain's Emmy Luo's ebastine, Italy's Bracco Xinyi company's dipatrol and other 4 original research drugs were selected, with an average price reduction of 67%.

Taking diabetes as an example,

The "life-saving medicine" for hundreds of millions of peopleGreat lightening

For many diabetic patients, when blood sugar is still poorly controlled after lifestyle intervention and oral hypoglycemic drugs, insulin It is an important treatment drug, and it can even be said to be a "life-saving drug".

Take insulin glargine, which is commonly used in clinic, as an example. The yuan is reduced to about 70 yuan per bottle, and each patient can save about 2,500 yuan per year.

According to the International Diabetes Federation (IDF) data, the number of people with diabetes in my country in 2021 will be 141 million, compared with 2019 116 million people, an increase of over 20%.

However, the "Guidelines for the Prevention and Treatment of Type 2 Diabetes in China (2020 Edition)" mentioned that the awareness rate, treatment rate and control of diabetes in my country The rates were 36.5%, 32.2%, and 49.2%, respectively.

The endocrinologist of a tertiary hospital believes that with the sharp price reduction of various insulins, the burden of patients' drug costs is reduced, and the penetration rate of insulin It is expected to improve, which will help improve the rational use of diabetes medication and enhance compliance, and will also promote more diabetic patients to do a good job in blood sugar control and reduce the occurrence of complications.

Can't wait!

When will the reduced-price medicines be available?

It is worth noting that since the establishment of the National Medical Insurance Bureau in 2018, it has carried out 7 batches of centralized procurement of nationally organized drugs, covering a total of For 294 kinds of medicines, the average price of medicines dropped by more than 50%.

Zhang Jie, deputy director of the National Organization Drug Joint Procurement OfficeEnsure that patients across the country can use these selected products after this centralized purchase price reduction in November 2022.

Produced by: Minsheng Weekly (ID: msweekly) New Media Department

Source: CCTV News, Southern Metropolis Daily

Editor: Jiang Yuhan

Editor in charge: Liu Yeye

Editor-in-Chief: Cui Jingfang

"People's Famous"

Understand different "people" domestic products and create extraordinary "famous products" for people's livelihood.

"People Travel"

Share your travel notes and strategies, show your beauty and food, and experience different scenery and customs on your behalf.

"Minsheng Weekly"

Hosted by the head of People's Daily, China's only news weekly that focuses on people's livelihood.